RESUMEN
Enterohemorrhagic Escherichia coli (EHEC), an enteropathogen that colonizes in the intestine, causes severe diarrhea and hemorrhagic colitis in humans by the expression of the type III secretion system (T3SS) and Shiga-like toxins (Stxs). However, how EHEC can sense and respond to the changes in the alimentary tract and coordinate the expression of these virulence genes remains elusive. The T3SS-related genes are known to be regulated by the locus of enterocyte effacement (LEE)-encoded regulators, such as Ler, as well as non-LEE-encoded regulators in response to different environmental cues. Herein, we report that OmpR, which participates in the adaptation of E. coli to osmolarity and pH alterations, is required for EHEC infection in Caenorhabditis elegans. OmpR protein was able to directly bind to the promoters of ler and stx1 (Shiga-like toxin 1) and regulate the expression of T3SS and Stx1, respectively, at the transcriptional level. Moreover, we demonstrated that the expression of ler in EHEC is in response to the intestinal environment and is regulated by OmpR in C. elegans. Taken together, we reveal that OmpR is an important regulator of EHEC which coordinates the expression of virulence factors during gastrointestinal infection in vivo.
Asunto(s)
Proteínas Bacterianas/genética , Caenorhabditis elegans/microbiología , Escherichia coli Enterohemorrágica/patogenicidad , Toxina Shiga I/biosíntesis , Transactivadores/genética , Factores de Virulencia/biosíntesis , Animales , Proteínas Bacterianas/metabolismo , Sistema Digestivo/microbiología , Escherichia coli Enterohemorrágica/genética , Proteínas de Escherichia coli/biosíntesis , Proteínas de Escherichia coli/genética , Regulación Bacteriana de la Expresión Génica/genética , Regiones Promotoras Genéticas/genética , Toxina Shiga I/genética , Transactivadores/biosíntesis , Transactivadores/metabolismo , Transcripción Genética/genética , Activación Transcripcional/genética , Sistemas de Secreción Tipo III/biosíntesis , Sistemas de Secreción Tipo III/genética , Factores de Virulencia/genéticaRESUMEN
BackgroundLaboratory-confirmed cases of Shiga toxin-producing Escherichia coli (STEC) have been notifiable to the National Notification System for Infectious Diseases in Switzerland since 1999. Since 2015, a large increase in case numbers has been observed. Around the same time, syndromic multiplex PCR started to replace other diagnostic methods in standard laboratory practice for gastrointestinal pathogen testing, suggesting that the increase in notified cases is due to a change in test practices and numbers.AimThis study examined the impact of changes in diagnostic methods, in particular the introduction of multiplex PCR panels, on routine STEC surveillance data in Switzerland.MethodsWe analysed routine laboratory data from 11 laboratories, which reported 61.9% of all STEC cases from 2007 to 2016 to calculate the positivity, i.e. the rate of the number of positive STEC tests divided by the total number of tests performed.ResultsThe introduction of multiplex PCR had a strong impact on STEC test frequency and identified cases, with the number of tests performed increasing sevenfold from 2007 to 2016. Still, age- and sex-standardised positivity increased from 0.8% in 2007 to 1.7% in 2016.ConclusionIncreasing positivity suggests that the increase in case notifications cannot be attributed to an increase in test numbers alone. Therefore, we cannot exclude a real epidemiological trend for the observed increase. Modernising the notification system to address current gaps in information availability, e.g. diagnostic methods, and improved triangulation of clinical presentation, diagnostic and serotype information are needed to deal with emerging disease and technological advances.
Asunto(s)
Toxinas Bacterianas/genética , Notificación de Enfermedades/normas , Infecciones por Escherichia coli/diagnóstico , Reacción en Cadena de la Polimerasa Multiplex/métodos , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , ADN Bacteriano/genética , Infecciones por Escherichia coli/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad , Vigilancia de Guardia , Serotipificación , Escherichia coli Shiga-Toxigénica/genética , Suiza/epidemiología , Adulto JovenRESUMEN
Shiga toxins (Stx) induce the symptoms of the life-threatening hemolytic uremic syndrome (HUS) and are the main virulence factors of enterohemorrhagic Escherichia coli (EHEC). The bacterial SOS response is the essential signal for high level production and release of Stx1/2. To assess the potential effectiveness of different antibiotics in blocking SOS response and Stx1/2 production, we constructed a reporter gene based test system that allows for the time-resolved, simultaneous read-out of the SOS response (recAP-cfp) and Stx1 production (stx1::yfp) in EHEC O157:H7 EDL933. We find that cells exposed to inhibitory or subinhibitory concentrations of ciprofloxacin did induce the SOS response, but not when the cells were exposed to rifaximine, azithromycin, tetracycline, gentamicin or ampicillin. Cell lysis and the peak in Stx1 production were substantially delayed with respect to the peak of the SOS response. We used this feature to show that adding transcriptional or translational inhibitors can block Stx1 production even after the SOS response is fully induced. RT-qPCR based tests with other clinically relevant EHEC isolates showed similar results for both Stx1 and Stx2. These observations suggest that transcriptional and translational inhibitors may be of value in treating EHEC infections.
Asunto(s)
Antibacterianos/farmacología , Escherichia coli Enterohemorrágica/genética , Respuesta SOS en Genética/efectos de los fármacos , Toxina Shiga I/genética , Ampicilina/farmacología , Pared Celular/efectos de los fármacos , Ciprofloxacina/farmacología , Escherichia coli Enterohemorrágica/efectos de los fármacos , Infecciones por Escherichia coli/tratamiento farmacológico , Genes Reporteros , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , Toxina Shiga I/biosíntesis , Transcripción Genética/efectos de los fármacosRESUMEN
Citric acid and EGCG at their minimum inhibitory concentrations were tested in this study. Logarithmic phase cells of Escherichia coli O157:H7 (ATCC 43895) were exposed to EGCG and citric acid respectively. The results of RT-real time PCR showed that both EGCG and citric acid increased stx2 and oxyR expression and decreased stx1, recA and Q expression. The result of Western blotting for RecA protein further indicated that both EGCG and citric acid decreased RecA production. Both EGCG and citric acid increased the level of intracellular reactive oxygen species and H2 O2 production and decreased superoxide dismutase activity. Therefore, EGCG and citric acid might induce stx2 production by increasing oxidative stress response and inhibit stx1 production by suppressing SOS response. In our study, the differential effects of the two antimicrobials were observed. EGCG reduced ompC and rpoS expression. However, citric acid caused an increase in ompC and rpoS expression. Membrane permeability is associated with toxin release. Citric acid increased the outer membrane permeability of E. coli O157:H7. However, the outer membrane of E. coli O157:H7 remained unaffected by EGCG. SIGNIFICANCE AND IMPACT OF THE STUDY: Shiga toxins are the major virulence factors of Escherichia coli O157:H7. The use of antimicrobials triggering Shiga toxin production is controversial. (-)-epigallocatechin-3-gallate (EGCG) citric acid are often used singly or in combination to prevent micro-organisms in some food products. This study evaluated toxin induction in E. coli O157:H7 in response to EGCG and citric acid and investigated the potential mechanism of action. The findings may contribute to the proper use of EGCG and citric acid as antimicrobials.
Asunto(s)
Antibacterianos/farmacología , Catequina/análogos & derivados , Permeabilidad de la Membrana Celular/efectos de los fármacos , Ácido Cítrico/farmacología , Escherichia coli O157/metabolismo , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Animales , Proteínas Bacterianas/biosíntesis , Catequina/farmacología , Escherichia coli O157/genética , Escherichia coli O157/patogenicidad , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Porinas/biosíntesis , Rec A Recombinasas/biosíntesis , Respuesta SOS en Genética/efectos de los fármacos , Factor sigma/biosíntesis , Virulencia , Factores de Virulencia/genética , Factores de Virulencia/metabolismoRESUMEN
High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin-producing E. coli strains recovered from patients in Michigan during 2010-2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistance could contribute to more severe disease outcomes.
Asunto(s)
Brotes de Enfermedades , Farmacorresistencia Bacteriana Múltiple , Infecciones por Escherichia coli/epidemiología , Escherichia coli O157/genética , Escherichia coli Shiga-Toxigénica/genética , Antibacterianos/farmacología , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/patología , Escherichia coli O157/clasificación , Escherichia coli O157/efectos de los fármacos , Escherichia coli O157/aislamiento & purificación , Hospitalización/estadística & datos numéricos , Humanos , Michigan/epidemiología , Pruebas de Sensibilidad Microbiana , Serogrupo , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Escherichia coli Shiga-Toxigénica/clasificación , Escherichia coli Shiga-Toxigénica/efectos de los fármacos , Escherichia coli Shiga-Toxigénica/aislamiento & purificaciónRESUMEN
An investigation of mortality of piglets through clinical signs, post-mortem, histopathology and bacteriological analyses revealed the causal organism to be Escherichia coli, mainly O149:K91:K88 which belongs to the enterotoxigenic biotypes. Molecular characterization and epidemiologic analysis elucidated it as shiga-toxin (ST) E. coli resistant to ampicillin, cefotaxime, tetracycline, trimethoprim-sulfamethoxazole, tylosin and neomycin. Conventional PCR results detected genes for ST-2, adhesin involved in diffuse adherence (AIDA-1) and F18 fimbriae virulence factors. Survival analyses and logistic regression of piglet mortality patterns showed that season of weaning, weaning weight and age of dam had significant influence on survival rate of piglets. Factors affecting pathogenicity of bowel edema and survival of affected piglets on a farm with persistent infection were reported for the first time. An association of E. coli O149:K91:K88 (F4) with clinical edema disease was made even though it has been reported in the past that this serotype does not produce ST. It was concluded that more stringent measures to mitigate the impact of the disease need to be targeted for spring and in older sows.
Asunto(s)
Brotes de Enfermedades/veterinaria , Escherichia coli Enterotoxigénica/genética , Infecciones por Escherichia coli/veterinaria , Enfermedades de los Porcinos/epidemiología , Adhesinas Bacterianas/genética , Animales , Farmacorresistencia Bacteriana Múltiple , Escherichia coli Enterotoxigénica/patogenicidad , Enterotoxinas/genética , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/mortalidad , Granjas , Proteínas Fimbrias/genética , Reacción en Cadena de la Polimerasa , Toxina Shiga/biosíntesis , Toxina Shiga I/biosíntesis , Sudáfrica/epidemiología , Análisis de Supervivencia , Porcinos , Enfermedades de los Porcinos/microbiología , Factores de Virulencia , DesteteRESUMEN
Fecal samples (n = 531) submitted to a regional clinical laboratory during a 6-month period were tested for the presence of Shiga toxin using both a Vero cell cytotoxicity assay and the Shiga Toxin Quik Chek test (STQC), a rapid membrane immunoassay. Testing the samples directly (without culture), 9 positives were identified by the Vero cell assay, all of which were also detected by the STQC. The correlation between the two assays was 100%. Not all of the identified positive samples were detected when fecal broth cultures were tested. By testing broth cultures of characterized isolates representing all described Shiga toxin subtypes, the STQC detected all subtypes. Levels of induction of toxin production by ciprofloxacin differed among the strains tested, with more toxin induction seen in strains harboring Stx2 phages than in those harboring Stx1 phages.
Asunto(s)
Ciprofloxacina/farmacología , Infecciones por Escherichia coli/diagnóstico , Escherichia coli O157/aislamiento & purificación , Heces/microbiología , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Animales , Línea Celular , Chlorocebus aethiops , Infecciones por Escherichia coli/microbiología , Humanos , Inmunoensayo/métodos , Células VeroRESUMEN
Shiga toxins (Stx) are primarily associated with Shiga toxin-producing Escherichia coli and Shigella dysenteriae serotype 1. Stx production by other shigellae is uncommon, but in 2014, Stx1-producing S. sonnei infections were detected in California. Surveillance was enhanced to test S. sonnei isolates for the presence and expression of stx genes, perform DNA subtyping, describe clinical and epidemiologic characteristics of case-patients, and investigate for sources of infection. During June 2014-April 2015, we identified 56 cases of Stx1-producing S. sonnei, in 2 clusters. All isolates encoded stx1 and produced active Stx1. Multiple pulsed-field gel electrophoresis patterns were identified. Bloody diarrhea was reported by 71% of case-patients; none had hemolytic uremic syndrome. Some initial cases were epidemiologically linked to travel to Mexico, but subsequent infections were transmitted domestically. Continued surveillance of Stx1-producing S. sonnei in California is necessary to characterize its features and plan for reduction of its spread in the United States.
Asunto(s)
Diarrea/epidemiología , Disentería Bacilar/epidemiología , Toxina Shiga I/biosíntesis , Shigella sonnei/genética , Adolescente , Adulto , Antibacterianos/uso terapéutico , California/epidemiología , Niño , Preescolar , Diarrea/microbiología , Diarrea/patología , Disentería Bacilar/microbiología , Disentería Bacilar/patología , Electroforesis en Gel de Campo Pulsado , Monitoreo Epidemiológico , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Toxina Shiga I/aislamiento & purificación , Shigella sonnei/clasificación , Shigella sonnei/aislamiento & purificaciónRESUMEN
BACKGROUND: Shiga toxin (Stx) is a common virulence factor of all Shiga toxin producing E. coli (STEC) that cause a wide spectrum of disease, including hemorrhagic colitis and hemolytic uremic syndrome (HUS). Although several commercial kits are available for detection of Stx produced by STEC, none of them are capable of recognizing all subtypes of Stxs, which include three subtypes of Stx1 and seven subtypes of Stx2. METHODS AND FINDINGS: New monoclonal and polyclonal antibodies against Stx1 and Stx2 were developed. A universal sandwich ELISA capable of detecting all known subtypes of Stx1 and Stx2 was established using a pool of newly developed antibodies. To precisely monitor the sensitivity of the assay for each subtype of Stxs, recombinant toxoids were created and used as standards in ELISAs. Because of the high affinity of the antibodies incorporated, the ELISA assay is highly sensitive with a limit of detection for the different subtypes of Stx1a and Stx2a between 10 and 50 pg/mL in phosphate buffered saline (PBS). The assay was also able to identify STEC based on the production of Stxs using the supernatants of culture fluids or even single colonies on agar plates without lengthy enrichment in liquid medium. When applied to ground beef samples, this newly developed ELISA was capable of distinguishing beef samples spiked with a single bacterial cell. CONCLUSIONS: A highly sensitive and universal assay for all subtypes of Stx1 and Stx2 was developed. It has significantly improved upon the current technologies by avoiding false negative results due to the narrow detection range of the assay. The assay developed in this study can be useful for prompt detection of new and emerging serotypes and screening ground beef samples for contamination of STEC at an early stage in the food supply chain, thus avoiding the need for possible recall.
Asunto(s)
Anticuerpos Antibacterianos/química , Anticuerpos Monoclonales/química , Ensayo de Inmunoadsorción Enzimática/métodos , Carne/microbiología , Toxina Shiga I/aislamiento & purificación , Toxina Shiga II/aislamiento & purificación , Animales , Anticuerpos Antibacterianos/biosíntesis , Anticuerpos Monoclonales/biosíntesis , Afinidad de Anticuerpos , Especificidad de Anticuerpos , Bovinos , Humanos , Límite de Detección , Carne/análisis , Ratones , Unión Proteica , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesisRESUMEN
Escherichia coli O157:H7 is a food-borne bacterium that causes hemorrhagic diarrhea and hemolytic uremic syndrome in humans. While cattle are a known source of E. coli O157:H7 exposure resulting in human infection, environmental reservoirs may also be important sources of infection for both cattle and humans. Bacteriophage-encoded Shiga toxins (Stx) carried by E. coli O157:H7 may provide a selective advantage for survival of these bacteria in the environment, possibly through their toxic effects on grazing protozoa. To determine Stx effects on protozoan grazing, we co-cultured Paramecium caudatum, a common ciliate protozoon in cattle water sources, with multiple strains of Shiga-toxigenic E. coli O157:H7 and non-Shiga toxigenic cattle commensal E. coli. Over three days at ambient laboratory temperature, P. caudatum consistently reduced both E. coli O157:H7 and non-Shiga toxigenic E. coli populations by 1-3 log cfu. Furthermore, a wild-type strain of Shiga-toxigenic E. coli O157:H7 (EDL933) and isogenic mutants lacking the A subunit of Stx 2a, the entire Stx 2a-encoding bacteriophage, and/or the entire Stx 1-encoding bacteriophage were grazed with similar efficacy by both P. caudatum and Tetrahymena pyriformis (another ciliate protozoon). Therefore, our data provided no evidence of a protective effect of either Stx or the products of other bacteriophage genes on protozoan predation of E. coli. Further research is necessary to determine if the grazing activity of naturally-occurring protozoa in cattle water troughs can serve to decrease cattle exposure to E. coli O157:H7 and other Shiga-toxigenic E. coli.
Asunto(s)
Escherichia coli O157/virología , Paramecium caudatum/fisiología , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Tetrahymena pyriformis/fisiología , Microbiología del Agua , Crianza de Animales Domésticos , Animales , Agentes de Control Biológico , Bovinos , Colifagos/genética , Recuento de Colonia Microbiana , Agua Potable/microbiología , Escherichia coli O157/crecimiento & desarrollo , Escherichia coli O157/patogenicidad , Cadena Alimentaria , Expresión Génica , Humanos , Toxina Shiga I/genética , Toxina Shiga II/genéticaRESUMEN
A novel procedure for the detection of specific DNA sequences has been developed. This procedure is based on the already known method employing PCR with appropriate primers and a sequence-specific DNA probe labeled with the fluorescent agent 6-carboxylfluorescein (FAM) at the 5' end and the fluorescence quencher BHQ-1 (black hole quencher) at the 3' end. However, instead of the detection of the fluorescence signal with the use of real-time PCR cyclers, fluorescence/luminescence spectrometers or fluorescence polarization readers, as in all previously-reported procedures, we propose visual observation of the fluorescence under UV light directly in the reaction tube. An example for the specific detection of the Shiga toxin-producing Escherichia coli (STEC) strains, by detecting Shiga toxin genes, is demonstrated. This method appears to be specific, simple, rapid and cost effective. It may be suitable for use in research laboratories, as well as in diagnostic units of medical institutions, even those equipped only with a thermocycler and a UV transilluminator, particularly if rapid identification of a pathogen is required.
Asunto(s)
ADN Bacteriano/genética , Toxinas Shiga/genética , Escherichia coli Shiga-Toxigénica/genética , Colifagos/genética , Genes Bacterianos/genética , Reacción en Cadena de la Polimerasa , Toxina Shiga I/biosíntesis , Toxina Shiga I/genética , Toxina Shiga II/biosíntesis , Toxina Shiga II/genética , Toxinas Shiga/análisis , Toxinas Shiga/biosíntesis , Escherichia coli Shiga-Toxigénica/metabolismo , Espectrofotometría UltravioletaRESUMEN
PCR-based testing for Shiga toxin producing Escherichia coli (STEC) directly from fecal samples is increasingly being implemented in routine diagnostic laboratories. These methods aim to detect clinically relevant amounts of microbes and not stx-carrying phages or low backgrounds of STEC. We present a diagnostic procedure and results from 1 year of stx-targeted real-time PCR of fecal samples from patients with gastrointestinal symptoms in Norway. A rapid stx2 subtyping strategy is described, which aims to quickly reveal the virulence potential of the microbe. stx was detected in 22 of 3320 samples, corresponding to a PCR positive rate of 0.66%. STEC were cultured from 72% of the PCR positive samples. Four stx1 isolates, eight stx2 isolates, and four isolates with both stx1 and stx2 were identified. With the method presented, stx-carrying phages are not commonly detected. Our results support the use of molecular testing combined with classical culture techniques for routine diagnostic purposes.
Asunto(s)
Heces/microbiología , Técnicas de Diagnóstico Molecular/métodos , Toxina Shiga I/genética , Toxina Shiga II/genética , Escherichia coli Shiga-Toxigénica/genética , Infecciones por Escherichia coli/diagnóstico , Microbiología de Alimentos , Humanos , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Escherichia coli Shiga-Toxigénica/clasificación , Escherichia coli Shiga-Toxigénica/aislamiento & purificaciónRESUMEN
Verocytotoxin-producing Escherichia coli (VTEC) strains of serotype O128ab:H2 were isolated from blood and stool of a 27-year-old male presenting diarrhea-associated hemolytic-uremic syndrome complicated by bacteremia. This report once again illustrates the pathogenic potential of a non-O157 VTEC strain carrying a virulence profile previously associated with mild disease.
Asunto(s)
Bacteriemia/microbiología , Infecciones por Escherichia coli/microbiología , Síndrome Hemolítico-Urémico/microbiología , Toxina Shiga I/biosíntesis , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Adulto , Diarrea/microbiología , Infecciones por Escherichia coli/diagnóstico , Heces/microbiología , Síndrome Hemolítico-Urémico/diagnóstico , Humanos , Masculino , Serotipificación , Escherichia coli Shiga-Toxigénica/clasificación , Escherichia coli Shiga-Toxigénica/metabolismo , Escherichia coli Shiga-Toxigénica/patogenicidadRESUMEN
In enterohaemorrhagic Escherichia coli (EHEC) O157, there are two types of anaerobic nitric oxide (NO) reductase genes, an intact gene (norV) and a 204 bp deletion gene (norVs). Epidemiological analysis has revealed that norV-type EHEC are more virulent than norVs-type EHEC. Thus, to reveal the role of NO reductase during EHEC infection, we constructed isogenic norV-type and norVs-type EHEC mutant strains. Under anaerobic conditions, the norV-type EHEC was protected from NO-mediated growth inhibition, while the norVs-type EHEC mutant strain was not, suggesting that NorV of EHEC was effective in the anaerobic detoxification. We then investigated the role of NO reductase within macrophages. The norV-type EHEC produced a lower NO level within macrophages compared with the norVs-type EHEC. Moreover, the norV-type EHEC resulted in higher levels of Shiga toxin 2 (Stx2) within macrophages compared with the norVs-type EHEC. Finally, the norV-type EHEC showed a better level of survival than the norVs-type EHEC. These data suggest that the intact norV gene plays an important role for the survival of EHEC within macrophages, and is a direct virulence determinant of EHEC.
Asunto(s)
Escherichia coli O157/genética , Escherichia coli O157/patogenicidad , Macrófagos/microbiología , Oxidorreductasas/genética , Factores de Virulencia/genética , Anaerobiosis/genética , Escherichia coli O157/metabolismo , Eliminación de Gen , Regulación Bacteriana de la Expresión Génica , Orden Génico , Macrófagos/metabolismo , Óxido Nítrico/metabolismo , Operón/genética , Oxidorreductasas/metabolismo , Toxina Shiga I/biosíntesis , Toxina Shiga I/genética , Factores de Virulencia/metabolismoRESUMEN
An outbreak of verotoxin-producing Escherichia coli O157 (VTEC O157) infections linked to an open farm occurred in eastern England in April and May 2007. This paper describes the investigation and highlights the importance of multidisciplinary collaboration for successful control of such outbreaks. There was a temporal cluster of 12 confirmed symptomatic cases of VTEC O157 and one asymptomatic carrier, from five families. The investigation revealed that four of these cases formed part of an outbreak involving two families who visited an open farm. The phenotypic and genotypic characteristics of the isolates from the two families and the putative farm animal contacts were indistinguishable, indicating that the animals were the source of the primary infections. No epidemiological link could be established between the remaining three families affected and the open farm or people having visited the farm. Control measures included improved hand washing facilities on the farm, information for visitors and staff, restricted access and suspended petting and feeding of animals, and thorough cleaning and disinfection of affected areas.
Asunto(s)
Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/transmisión , Escherichia coli O157/aislamiento & purificación , Toxina Shiga I/biosíntesis , Adolescente , Adulto , Crianza de Animales Domésticos , Animales , Niño , Preescolar , Análisis por Conglomerados , Brotes de Enfermedades/prevención & control , Inglaterra/epidemiología , Infecciones por Escherichia coli/diagnóstico , Infecciones por Escherichia coli/microbiología , Escherichia coli O157/genética , Composición Familiar , Heces/microbiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Toxina Shiga I/análisis , Encuestas y Cuestionarios , Adulto JovenRESUMEN
We characterized 97 non-O157 Shiga toxin (stx)-producing Escherichia coli strains isolated from human patients during 2000-2009 from the national reference laboratory in Switzerland. These strains belonged to 40 O:H serotypes; 4 serotypes (O26:H11/H-, O103:H2, O121:H19, and O145:H28/H-) accounted for 46.4% of the strains. Nonbloody diarrhea was reported by 23.2% of the patients, bloody diarrhea by 56.8%. Hemolytic uremic syndrome developed in 40.0% of patients; serotype O26:H11/H- was most often associated with this syndrome. Forty-five (46.4%) strains carried stx2 genes only, 36 strains (37.1%) carried stx1, and 16 (16.5%) strains carried stx1 and stx2. Genes encoding enterohemolysin and intimin were detected in 75.3% and 70.1% of the strains, respectively. Resistance to ≥1 antimicrobial agent was present in 25 isolates. High genetic diversity within strains indicates that non-O157 stx-producing E. coli infections in Switzerland most often occurred as single cases.
Asunto(s)
Infecciones por Escherichia coli/epidemiología , Síndrome Hemolítico-Urémico/epidemiología , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Escherichia coli Shiga-Toxigénica/clasificación , Escherichia coli Shiga-Toxigénica/patogenicidad , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Electroforesis en Gel de Campo Pulsado , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/fisiopatología , Femenino , Síndrome Hemolítico-Urémico/microbiología , Síndrome Hemolítico-Urémico/fisiopatología , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Serotipificación , Escherichia coli Shiga-Toxigénica/genética , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Especificidad de la Especie , Suiza , Adulto JovenRESUMEN
Cattle are a primary reservoir of Escherichia coli O157:H7, a major foodborne pathogen. The organism causes haemorrhagic colitis which can lead to serious complications, including haemolytic-uraemic syndrome. Although E. coli O157:H7 is widely prevalent in cattle and cattle environments, the number of human cases remain relatively low, suggesting possible strain diversity and differences in virulence between human and bovine strains. Shiga toxins, Stx1 and Stx2, are the major virulence factors. Differences in Stx2 production between human and bovine strains have been demonstrated previously, and isolates possessing the stx2 gene, but not producing Stx2 [toxin non-producing (TNP) strains] have been identified. In this study, 150 isolates (56 human, 94 bovine) were tested by PCR for stx2 upstream regions associated with TNP and the Q933 gene, which has been previously associated with toxin production. A reverse passive latex agglutination test was used to evaluate 107 isolates (50 human, 57 bovine) for Stx1 and Stx2 production. The percentages of human and bovine isolates positive for presence of the TNP regions were similar (57.1% and 53.1% respectively), while a higher percentage of human isolates was positive for Q933 gene (89.3% versus 54.3%). Stx2 production of ≥ 1:8 was found in 86.0% of human isolates compared with 26.3% of bovine isolates. Bovine isolates with the presence of the TNP regions were associated with significantly lower Stx2 production (P < 0.05), while the Q933 gene was associated with higher Stx2 production (P < 0.05). However, the presence of the TNP region was not associated (P > 0.05) with low Stx2 production in human isolates. Therefore, Q933 was a better indicator of high Stx2 production by human and bovine isolates and may be a useful screening method to assess their potential to cause human disease.
Asunto(s)
Enfermedades de los Bovinos/microbiología , Infecciones por Escherichia coli/microbiología , Escherichia coli O157/genética , Toxina Shiga II/genética , Animales , Bovinos , Cartilla de ADN , Escherichia coli O157/patogenicidad , Genes Bacterianos , Genes vif , Variación Genética , Humanos , Kansas , Modelos Logísticos , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Toxina Shiga I/biosíntesis , Toxina Shiga I/genética , Toxina Shiga II/biosíntesis , Escherichia coli Shiga-Toxigénica/genéticaAsunto(s)
Colifagos , Escherichia coli Enterohemorrágica/genética , Escherichia coli Enterohemorrágica/patogenicidad , Expresión Génica , Toxina Shiga I/biosíntesis , Toxina Shiga II/biosíntesis , Colifagos/química , Colifagos/genética , Colifagos/fisiología , Escherichia coli Enterohemorrágica/metabolismo , Genoma Bacteriano/genética , Regiones Promotoras Genéticas/genética , Toxina Shiga I/química , Toxina Shiga I/genética , Toxina Shiga I/metabolismo , Toxina Shiga II/química , Toxina Shiga II/genética , Toxina Shiga II/metabolismo , Transcripción GenéticaRESUMEN
Escherichia coli strains that produce Shiga toxin 2 (Stx2) are isolated from hemolytic-uremic syndrome (HUS) cases more frequently than are strains that produce both Shiga toxin 1 (Stx1) and Stx2, whereas strains that produce only Stx1 are rarely isolated from HUS cases. Studies have implicated Stx2 as the sole contributor to acute kidney failure and other systemic complications in humans. The aim of the present study was to determine whether Stx2-specific antibody would be as effective against Shiga toxin-producing Escherichia coli (STEC) strains that produce both Stx1 and Stx2 as it is against strains that produce only Stx2, compared with Stx1-specific antibody. We found that Stx2-specific and Stx1-specific antibodies protected 100% and 0% of piglets, respectively, against oral challenge with a Stx1- and Stx2-producing STEC strain. We conclude that Stx2-specific antibody is sufficient to protect piglets, and possibly humans, against STEC strains that produce both toxins.